08/14/2025
6:53 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2025
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2025
6:36 AM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2025
9:38 AM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2025
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2025
11:01 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2025
5:25 PM | CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:18 PM | CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
05/15/2025
6:50 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2025
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2025
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for GALT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Galectin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/31/2025
6:50 AM | Galectin Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/31/2025
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
3:00 PM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2025
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2025
11:40 AM | Galectin Therapeutics (Issuer)
Shlevin Harold H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2025
3:03 PM | CARSON BENJAMIN SR (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:03 PM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:04 PM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:05 PM | Galectin Therapeutics (Issuer)
Jamil Khurram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:06 PM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:06 PM | Galectin Therapeutics (Issuer)
OMENN GILBERT S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:07 PM | Galectin Therapeutics (Issuer)
Rubin Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:01 PM | Galectin Therapeutics (Issuer)
OMENN GILBERT S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:02 PM | CALLICUTT JACK W (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
10:15 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
6:45 AM | Galectin Therapeutics (Issuer)
Shlevin Harold H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:20 AM | Galectin Therapeutics (Issuer)
Jamil Khurram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:16 AM | Galectin Therapeutics (Issuer)
Zordani Richard A. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:18 AM | CALLICUTT JACK W (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:18 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:02 AM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:07 AM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:17 PM | CALLICUTT JACK W (Reporting)
Galectin Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/23/2024
3:18 PM | Galectin Therapeutics (Subject)
LEWIS JOEL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/23/2024
3:19 PM | Galectin Therapeutics (Subject)
Jamil Khurram (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2024
6:50 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
7:03 AM | Galectin Therapeutics (Filer)
| Form DEF 14A | |
New law could create $3.7 trillion tsunami. (Ad) During a meeting in Washington D.C., Jeff Brown discovered a bold initiative.
He calls it “President Trump’s Project MAFA,” and it could soon return America to a “new” gold standard.
The Trump administration, Wall Street, and Silicon Valley are all pushing it forward. The President himself calls the plan “incredible.”
Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%. You can watch it right here. |
12/03/2024
7:04 AM | Galectin Therapeutics (Filer)
| Form DEFA14A | |
12/03/2024
7:05 AM | Galectin Therapeutics (Filer)
| Form ARS | |
11/14/2024
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
6:51 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2024
12:39 PM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
3:12 PM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:10 PM | Boudes Pol F (Reporting)
Galectin Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
7:08 AM | Galectin Therapeutics (Issuer)
Zordani Richard A. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
MarketBeat All Access